05.04.2005 23:01:00

Allergan Announces Quarterly Conference Call

Allergan Announces Quarterly Conference Call


    Business Editors/Financial Analysts

    IRVINE, Calif.--(BUSINESS WIRE)--April 5, 2005--Allergan, Inc. (NYSE:AGN) invites you to listen to David Pyott, Chairman of the Board, President and Chief Executive Officer, and Eric Brandt, Executive Vice President, Finance, Strategy & Corporate Development and Chief Financial Officer, discuss the Company's 2005 first quarter results on Wednesday, April 27, 2005. The live Web cast can be accessed through the Allergan Web site, www.allergan.com, beginning at 8:00 a.m. Pacific Time. A replay of the discussion will also be available from Wednesday, April 27, 2005 at 11:00 a.m. Pacific Time until Tuesday, May 3, 2005 at 5:00 p.m. Pacific Time and can be accessed through www.allergan.com, 1-866-373-9229 for domestic locations, or 1-203-369-0281 for international locations. A passcode will not be required.
    It is Allergan's policy to comply fully with Regulation FD. Therefore, Allergan intends to utilize this Web-casted event to discuss financially oriented goals and objectives and to disclose material Company and industry-based topics in an open manner. The Company does not plan to report or comment on its progress during the current fiscal quarter. Any statement made by others with respect to progress mid-quarter cannot be attributed to the Company. During a quarter, the Company's commentary will be limited to discussions of public information, such as historic financial performance, and matters that are deemed to be immaterial. Allergan will make no comments with respect to market rumors or speculation.

--30--KG/np*

CONTACT: Allergan, Inc., Irvine Jim Hindman, Joann Bradley or Ashwin Agarwal 714-246-4636

KEYWORD: CALIFORNIA INDUSTRY KEYWORD: PHARMACEUTICAL CONFERENCE CALLS SOURCE: Allergan, Inc.

Copyright Business Wire 2005

JETZT DEVISEN-CFDS MIT BIS ZU HEBEL 30 HANDELN
Handeln Sie Devisen-CFDs mit kleinen Spreads. Mit nur 100 € können Sie mit der Wirkung von 3.000 Euro Kapital handeln.
82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren.

Nachrichten zu Allergan Inc.mehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Allergan Inc.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Indizes in diesem Artikel

S&P 500 6 032,38 0,56%